Ilex Medical Ltd (TLV:ILX)

Ilex Medical Statistics

Total Valuation

Ilex Medical has a market cap or net worth of ILS 713.91 million. The enterprise value is 514.02 million.

Market Cap	713.91M
Enterprise Value	514.02M

Important Dates

The last earnings date was Sunday, August 24, 2025.

Earnings Date	Aug 24, 2025
Ex-Dividend Date	Apr 7, 2025

Share Statistics

Ilex Medical has 11.19 million shares outstanding.

Current Share Class	11.19M
Shares Outstanding	11.19M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	62.77%
Owned by Institutions (%)	12.67%
Float	2.84M

Valuation Ratios

The trailing PE ratio is 15.65.

PE Ratio	15.65
Forward PE	n/a
PS Ratio	0.77
PB Ratio	1.08
P/TBV Ratio	1.12
P/FCF Ratio	21.90
P/OCF Ratio	12.12
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.12, with an EV/FCF ratio of 15.77.

EV / Earnings	11.27
EV / Sales	0.56
EV / EBITDA	5.12
EV / EBIT	9.75
EV / FCF	15.77

Financial Position

The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.07.

Current Ratio	3.09
Quick Ratio	2.26
Debt / Equity	0.07
Debt / EBITDA	0.43
Debt / FCF	1.43
Interest Coverage	17.56

Financial Efficiency

Return on equity (ROE) is 7.87% and return on invested capital (ROIC) is 5.49%.

Return on Equity (ROE)	7.87%
Return on Assets (ROA)	3.92%
Return on Invested Capital (ROIC)	5.49%
Return on Capital Employed (ROCE)	8.38%
Revenue Per Employee	5.18M
Profits Per Employee	256,213
Employee Count	178
Asset Turnover	0.95
Inventory Turnover	4.43

Taxes

In the past 12 months, Ilex Medical has paid 18.71 million in taxes.

Income Tax	18.71M
Effective Tax Rate	26.94%

Stock Price Statistics

The stock price has increased by +2.75% in the last 52 weeks. The beta is -0.14, so Ilex Medical's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	+2.75%
50-Day Moving Average	6,088.44
200-Day Moving Average	6,605.41
Relative Strength Index (RSI)	62.96
Average Volume (20 Days)	2,257

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ilex Medical had revenue of ILS 922.54 million and earned 45.61 million in profits.

Revenue	922.54M
Gross Profit	214.02M
Operating Income	61.05M
Pretax Income	69.43M
Net Income	45.61M
EBITDA	95.15M
EBIT	61.05M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 246.61 million in cash and 46.72 million in debt, giving a net cash position of 199.89 million or 17.87 per share.

Cash & Cash Equivalents	246.61M
Total Debt	46.72M
Net Cash	199.89M
Net Cash Per Share	17.87
Equity (Book Value)	660.36M
Book Value Per Share	n/a
Working Capital	456.84M

Cash Flow

In the last 12 months, operating cash flow was 58.91 million and capital expenditures -26.31 million, giving a free cash flow of 32.60 million.

Operating Cash Flow	58.91M
Capital Expenditures	-26.31M
Free Cash Flow	32.60M
FCF Per Share	2.91

Margins

Gross margin is 23.20%, with operating and profit margins of 6.62% and 4.94%.

Gross Margin	23.20%
Operating Margin	6.62%
Pretax Margin	7.53%
Profit Margin	4.94%
EBITDA Margin	10.31%
EBIT Margin	6.62%
FCF Margin	3.53%

Dividends & Yields

This stock pays an annual dividend of 1.22, which amounts to a dividend yield of 1.91%.

Dividend Per Share	1.22
Dividend Yield	1.91%
Dividend Growth (YoY)	-10.63%
Years of Dividend Growth	n/a
Payout Ratio	29.91%
Buyback Yield	n/a
Shareholder Yield	1.91%
Earnings Yield	6.39%
FCF Yield	4.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 21, 2000. It was a forward split with a ratio of 9.

Last Split Date	Aug 21, 2000
Split Type	Forward
Split Ratio	9

Scores

Altman Z-Score	n/a
Piotroski F-Score	5